Skip to content

   Pharma Publications

Neuropsychopharmacology
  • Neurogenesis-independent mechanisms of MRI-detectable hippocampal volume increase following electroconvulsive stimulation
    Published on 2024-01-08
    3 years ago
  • Advances in precision neuromodulation: electroconvulsive therapy amplitude titration
    Published on 2024-01-08
    3 years ago
  • Academic ethics of mental health: the national black postdocs framework for the addressment of support for undergraduate and graduate trainees
    Published on 2024-01-07
    3 years ago
  • Polygenic liability for antipsychotic dosage and polypharmacy – a real-world registry and biobank study
    Published on 2024-01-05
    3 years ago
  • Modulation of learning safety signals by acute stress: paraventricular thalamus and prefrontal inhibition
    Published on 2024-01-04
    3 years ago
  • Comparative rhythmic transcriptome profiling of human and mouse striatal subregions
    Published on 2024-01-04
    3 years ago
  • Correction: Psychosocial moderators of polygenic risk scores of inflammatory biomarkers in relation to GrimAge
    Published on 2024-01-04
    3 years ago
« Previous 1 … 109 110 111 112 113 … 143 Next »
Journal of Psychopharmacology
  • Cariprazine modulates sleep architecture in rats
    Published on 2021-01-07
    6 years ago
  • Efficacy of N-methyl-D-aspartate receptor modulator augmentation in schizophrenia: A meta-analysis of randomised, placebo-controlled trials
    Published on 2021-01-07
    6 years ago
  • Acute acetate administration increases endogenous opioid levels in the human brain: A [11C]carfentanil molecular imaging study
    Published on 2021-01-07
    6 years ago
  • Pharmacotherapy of attention deficit/hyperactivity disorder in individuals with autism spectrum disorder: A systematic review of the literature
    Published on 2020-12-22
    6 years ago
  • A comparison of MDMA-assisted psychotherapy to non-assisted psychotherapy in treatment-resistant PTSD: A systematic review and meta-analysis
    Published on 2020-12-21
    6 years ago
  • Mystical-type experiences occasioned by ketamine mediate its impact on at-risk drinking: Results from a randomized, controlled trial
    Published on 2020-12-14
    6 years ago
  • Dopaminergic neuromodulation has no detectable effect on visual-cue induced haemodynamic response function in the visual cortex: A double-blind, placebo-controlled functional magnetic resonance imaging study
    Published on 2020-12-14
    6 years ago
« Previous 1 … 109 110 111 112 113 … 154 Next »
European Neuropsychopharmacology
  • Psychonauts’ psychedelics: A systematic, multilingual, web-crawling exercise
    Published on 2021-04-13
    5 years ago
  • Are we ready for precision medicine for Autism? And who wants it?
    Published on 2021-04-12
    5 years ago
  • The effect of family environment and psychiatric family history on psychosocial functioning in first-episode psychosis at baseline and after 2 years
    Published on 2021-04-12
    5 years ago
  • Drug development in ASD, an ISCTM-ECNP joint adventure
    Published on 2021-04-06
    5 years ago
  • GABAA receptor agonist cinazepam and its active metabolite 3-hydroxyphenazepam act differently at the presynaptic site
    Published on 2021-04-03
    5 years ago
  • Reinforcement learning abnormalities in the attenuated psychosis syndrome and first episode psychosis
    Published on 2021-04-03
    5 years ago
  • Systematic comparison of duration of untreated illness versus duration of untreated psychosis in relation to psychopathology and dysfunction in the Cavan-Monaghan first episode psychosis study (CAMFEPS)
    Published on 2021-04-03
    5 years ago
« Previous 1 … 109 110 111 112 113 … 170 Next »

   Pharma Pub